BrightSpring Health Services Inc header image

BrightSpring Health Services Inc

BTSG

Equity

ISIN null / Valor 131996976

NASDAQ (2025-11-19)
USD 32.26+2.25%

BrightSpring Health Services Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

BrightSpring Health Services Inc. is a prominent provider of home- and community-based health services, catering to complex populations requiring specialized or chronic care. The company offers a range of services including home health care, hospice, and home care for seniors, as well as long-term specialty care for behavioral and neuro rehabilitation patients. Additionally, BrightSpring provides pharmacy therapy management across various settings. The company leverages advanced technology and processes, such as electronic health record solutions, data analytics, telehealth, and smart home monitoring, to enhance care delivery and management. BrightSpring is also focused on growth through strategic acquisitions and new business opportunities, aiming to expand its reach and impact in the health and human services sector.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (06.10.2025):

BrightSpring Health Services Inc. reported strong financial performance for the fourth quarter and full year of 2024, demonstrating significant growth in revenue and improved profitability. The company also raised its revenue and Adjusted EBITDA guidance for the full year 2025, reflecting continued optimism in its business trajectory.

Q4 2024 Revenue Growth

BrightSpring achieved a fourth-quarter net revenue of $3,053 million, marking a 28.6% increase compared to $2,375 million in Q4 2023.

Improved Net Income

The company reported a net income of $15.4 million for Q4 2024, a notable improvement from a net loss of $7.2 million in the same quarter last year.

Adjusted EBITDA Increase

Adjusted EBITDA for Q4 2024 rose by 17.4% to $167 million, up from $143 million in Q4 2023.

Full Year 2024 Performance

For the full year 2024, BrightSpring reported net revenue of $11,266 million, a 27.6% increase from $8,826 million in 2023. The company also reduced its net loss to $20.5 million from $156.8 million in the previous year.

Strategic Divestiture

BrightSpring entered into a definitive agreement to divest its Community Living business to Sevita for $835 million, enhancing its strategic focus and financial flexibility.

Increased 2025 Guidance

The company raised its 2025 revenue guidance to between $11,600 million and $12,100 million and its Adjusted EBITDA guidance to between $545 million and $560 million, excluding the Community Living business.

Summarized from source with an LLMView Source

Key figures

73.0%1Y
%3Y
%5Y

Performance

46.6%1Y
44.4%3Y
44.4%5Y

Volatility

Market cap

5818 M

Market cap (USD)

Daily traded volume (Shares)

2,788,408

Daily traded volume (Shares)

1 day high/low

17.18 / 16.65

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

AMN Healthcare Services Inc
AMN Healthcare Services Inc AMN Healthcare Services Inc Valor: 1269241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.94%USD 15.78
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.22%EUR 9.03
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%EUR 26.45
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.79%EUR 46.69
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.86%EUR 35.30
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 24.88
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%USD 70.53
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 67.95
M1 Kliniken AG
M1 Kliniken AG M1 Kliniken AG Valor: 29694419
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.92%EUR 15.90
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 11.50